9Indexed trials
mesh condition
Lennox Gastaut Syndrome
Intelligence
Lennox Gastaut Syndrome intelligence: 9 indexed trials, 2 recruiting studies, 7 sponsors across 20 countries.
2Recruiting
7Sponsors
20Countries
Leading sponsors
Jazz Pharmaceuticals22 recruiting
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.20 recruiting
Gillette Children's Specialty Healthcare10 recruiting
NYU Langone Health10 recruiting
SK Life Science, Inc.10 recruiting
Longboard Pharmaceuticals10 recruiting
Janssen Cilag Pharmaceutica S.A.C.I., Greece10 recruiting
Geographic activity
United States7trials
Italy3trials
Australia2trials
Belgium2trials
France2trials
Germany2trials
Japan2trials
Mexico2trials
Spain2trials
Sweden1trials
Latvia1trials
United Kingdom1trials
Leading interventions
Cannabidiol2trials
Cannabidiol Oral Solution1trials
Carisbamate1trials
Epidiolex 100 mg/mL Oral Solution1trials
LP3521trials
Matching Placebo1trials
Topiramate1trials
Turmeric1trials
ZX008 0.2 or 0.8 mg/kg/day1trials
12-Lead ECG1trials
ZX008 0.2 to 0.8 mg/kg/day1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.